within the same patient, as well as between two groups. Traditionally, clinical symptoms and signs were used as outcome measures. Some studies used generic quality of life measures like SF-36 to assess the outcome after carpal tunnel release [1, 7] . Levine et al. [18] in 1993 introduced the first disease-specific questionnaire, the Boston Carpal Tunnel Questionnaire (BCTQ), to assess the outcome after carpal tunnel release. Since then, various other upper-limb outcome measures have been used in the assessment of carpal tunnel patients. Some of the commonly used outcomes measures, identified by our literature search, are Disability of Arm, Shoulder and Hand (DASH) [8, 10, 11, 15, 22] , clinical rating system (Hi-Ob scale) [9, 20] , Patient Evaluation Measure (PEM) [6, 12, 19] , Michigan Hand Outcome Questionnaire (MHQ) [3, 4, 16] and Upper Extremity Functional Scale (UEFS) [21] . In this article, we studied the development process, the validation process, reliability, internal consistency (IC) and the sensitivity testing process of each outcome measure used in CTS and we also evaluated the advantages, disadvantages and appropriateness of some of the outcome measures used for the assessment of patients with CTS.
Materials and methods
In this study, we conducted an extensive literature search to identify all of the outcome measures used in the assessment of patients with CTS. We restricted our search to reports in the English literature. We searched Medline, EMBASE and CINAHL using the OVID interface. We also searched other interfaces like EBSCO, Academic Search Premier and Proquest, as well as individual publishers' websites such as MDconsult, Science Direct, Lippincott Wilkins and Williams (LWW), Lippincott Ravens, Blackwell Synergy, Wiley Interscience, Taylor and Francis and Springerlink. We used search terms such as "carpal tunnel," "outcome measures," "outcome scale," "assessment scale," "diseasespecific questionnaire," "patient-generated questionnaire" and "patient-oriented questionnaire" either alone or in different combinations. Our search identified six outcome measures that are commonly used in the assessment of patients with CTS. We then critically evaluated the construction framework, development and validation process, reliability and sensitivity assessment, appropriateness and limitations of each outcome measure.
Factors to be considered when selecting an outcome measure for any disorder Different authors like Bindra et al. [2] , Szabo [24] and Schuind et al. [23] have reviewed various aspects of outcome measures used in hand surgery. Schuind et al. [23] reviewed the various outcome measures used for hand and upper-extremity disorders and emphasised the need for a comprehensive outcome assessment process including objective, subjective and laboratory criterion. Bindra et al. [2] , in their review, highlighted the importance of considering factors like the stages in the development of a questionnaire, attributes of a questionnaire and factors that affect filling the questionnaire. Based on these studies, patients' input and our own experience, we listed the factors which are required for the selection of an outcome measure (Table 1) . We analysed the outcome measures used in CTS based on these variables and have given some suggestions based on our analysis.
Item generation and item reduction
An ideal outcome measure should have the item generation process clearly described, involve experts, patients and previous literature in the item generation process, clearly explain the item reduction process and should have performed a factor analysis to verify its factor structure.
Variables measured
An ideal outcome measure should include patient-oriented outcome variables, such as pain, symptoms scale, function scale, satisfaction scale and objective variables including clinical signs, physical examination findings, experimental and laboratory tests.
Type of outcome measure
Ideally, the outcome should be reported with one generic measure to compare with the disability and quality of life associated with other disorders, one region-specific measure Table 1 Variables to be considered when selecting an outcome measure Variables 1.
Generic, disease-specific or region-specific 2.
Patient-oriented, clinical, lab-based or combined 3.
Item generation-patient-generated, physician-generated or both 4.
Patient-filled, physician-filled or combined 5.
Validity established for that particular disease (content, criterion, construct, cross-cultural, factor analysis and longitudinal validity) 6.
Reliable (IC and test-retest reliability) 7.
Sensitiveness or responsiveness 8.
Easy to fill with less assistance 9.
Less time consuming 10. Acceptable 11. Easily available with no copyright or cost restrictions 12. Quantitative and amenable to statistical analysis 13. Standardised for the disease and normal population to enable comparison with disease of the same region and one disease-specific measure to enable comparisons of outcome following different treatments and to identify subtle alterations in the disease-related health status and quality of life.
Validation
An ideal outcome measure must have acceptable face validity, content validity, construction validity, criterion validity and longitudinal validity. They should show similar validation results in the hands of the developers and also in the hands of independent researchers (generalisability). The outcome should have good cross-cultural validity.
Reliability
An ideal outcome measure should have very good testretest reliability and a well established memory recall period. The reliability is considered good if it is statistically significant or, according to Landis and Koch [17] , a Kappa of 0.21 to 0.40 is considered to be fair, 0.41 to 0.60 moderate, 0.61 to 0.80 substantial and 0.81 to 1.0 as excellent. Similarly, the items should be internally consistent with a minimum Cronbach's alpha of 0.6.
Responsiveness
An outcome measure should have a high standardised response mean (SRM) and high effect size. According to Cohen, an SRM of 0.2 is small, 0.5 is medium and 0.8 is large [5] .
Other aspects of an ideal outcome measure An outcome measure should be free of cost and easy to fill in without missing too many questions with good response rate, and the time needed to fill the questionnaire in should be clearly established and it should be appropriate in clinical (outpatient, inpatient) and research settings. The outcome variable should have a final quantitative value which can be used for statistical comparisons. Above all, the outcome measure should have high acceptability among clinicians and researchers.
Boston Carpal Tunnel Syndrome Questionnaire (BCTQ)
Conceptual framework BCTQ is the most commonly used outcome measure in the assessment of patients with CTS. Levine et al. [18] developed this questionnaire in 1993. This is a diseasespecific patient-filled questionnaire. Both physicians and patients were involved in the item generation process. Domains in the questionnaire were decided by the patients and physicians, and factorial analysis was not performed by the developers to check the domain structure of the questionnaire. The questionnaire comprises two scales, a symptom severity scale and a functional status scale ( Table 2 ). The symptom severity scale has 11 questions scored from 1 point (mildest) to 5 points (most severe). The similarly functional status scale has eight questions scored from 1 point (no difficulty with activity) to 5 points (cannot perform the activity at all). The overall score for both scales was calculated as the mean of the items. The scale was tested on 38 patients who had surgical treatment of CTS.
Validity
The developers checked the criterion validity by comparing the score with grip strength, pinch strength, two-point discrimination and pressure sensitivity, and this correlated well with these variables in the expected direction. Crosscultural validation has been performed in the Italian, Swedish and Portuguese languages.
Reliability
The scales were highly reproducible and internally consistent in the hands of the developer, with a reproducibility of r=0.91 for symptom severity scale and r=0.93 for functional status scale IC (Cronbach's alpha) of 0.89 for the symptom severity scale and 0.91 for the functional status scale.
Responsiveness
The developers noticed very good responsiveness with an effect size (ES) of 1.4 for the symptom severity scale and 0.82 for the functional scale. Similarly, high responsiveness was shown by other researchers, such as Greenslade et al. [10] (SRM of 1.02 for the symptom scale and 0.62 for the functional scale at 3 months ) and Gay et al. [7] (SRM/ES of 1.21/1.30 and 1.66/1.71, 0.46/0.48 and 1.05/1.05, 1.67/ 1.74 and 2.01/1.96 for the whole questionnaire, symptom scale and functional scale at 6 weeks and 12 weeks, respectively). They also demonstrated that the questionnaire does not have ceiling or floor effects.
Limitations
Even though the reliability, responsiveness and criterion validity has been well established over the years, the construction and domain structure were never validated, either by the developers or by independent researchers. Similarly, this questionnaire was not validated in patients claiming for workers compensation, thereby, precluding its Table 2 Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) [18] , clinical rating scale (Hi-Ob scale) [9] , Patient Evaluation Measure (PEM) [19] Boston Carpal Tunnel Syndrome Questionnaire Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) Symptom severity scale (11 items Are there any other comments you wish to make? Thank you very much indeed for your help use in this set of patients. The time required to fill in this questionnaire is not clearly established and nor are the commonly missed items not mentioned by developers or independent researchers. Despite these limitations, this questionnaire continues to be the most commonly used in the assessment of patients with CTS.
Upper Extremity Functional Scale (UEFS)

Conceptual framework
This scale was developed in 1997 by Pransky et al. [21] . It is a region-specific questionnaire developed to assess the outcome of work-related upper extremity disorders. This scale is a patient-filled questionnaire measuring the functional component of physical health and has eight items derived from a pool of 12 items generated by physicians, patients and occupational therapists. The item responses were on a 1-10 response scale for CTS, with 1 being no problem with that particular activity and 10 being cannot do it at all (Table 3 ). This scale was tested on 165 patients with CTS.
Validity
Principal component factor analysis revealed that 42% to 56% of the inter-item variance was explained by a single factor. Also, no other factor was found with high Eigen values. Validity was also established by demonstrating varying UEFS scores for patients with varying duration of symptoms and the impact of illness on working status. It was validated further by demonstrating a high degree of correlation between the UEFS score and other continuous measures of self-reported pain, psychological measure and physical examinations.
Reliability
The IC was found be excellent for patients with CTS, with alpha ranging from 0.83 to 0.93 for the various items.
Responsiveness
High responsiveness was established by showing a high correlation between change in UEFS to change in other measures of disease and also by demonstrating variable SRM in surgical subgroups as compared to non-surgical patients.
Other features
The authors also demonstrated the absence of floor effects. The scale is readily available electronically and its use for scientific and clinical purposes is unrestricted.
Limitations
The scale measures only the functional component of physical health and does not measure the symptoms nor objective components of physical, social and mental health. This scale has not gained wide acceptance for the assessment of CTS. It has also not undergone crosscultural validation. Its validity, reliability and responsiveness has not been checked by independent researchers, apart from the developers. The time to fill in this questionnaire, the degree of assistance needed from the physician and the questions commonly missed are not mentioned. It is not standardised for a normal population and the influences of age, worker compensation issues and psychological status on the score has not be studied. Further, the items are not weighted and the test-retest reliability was never assessed.
Michigan Hand Outcomes Questionnaire (MHQ)
Conceptual framework
This questionnaire was developed by Chung et al. [4] in 1998 for the assessment of outcome for various hand disorders. The 37 items in the questionnaire were from a pool of 100 questions which was reduced by factor analysis. The 37 items are grouped into six domains: (1) overall hand function, (2) activity of daily living, (3) pain, (4) work performance, (5) aesthetics and (6) patient satisfaction with hand function. This scale was tested prospectively on a population of 200 patients with varying hand disorders, including those with CTS.
Validity
The developers also verified the construction of 37 items in six hypothetical subscales by factor analysis and 
Reliability
The developers showed the test-retest reliability from 0.81 to 0.97 and IC from 0.86 to 0.97 for various subscales.
Responsiveness
Kotsis and Chung [16] noted that the SRM varied from 0.5 to 0.6 for the activity subscale and from 0.9 to 1.1 for the pain and satisfaction scale, thereby, establishing its responsiveness.
Other features
This scale is electronically available and its use is unrestricted for clinical and research purpose. Both weighted and unweighted questionnaires were tested and no definite differences were found by the developer. Hence, an unweighted score was recommended for simplicity. The developer states the mean time to fill in the questionnaire was 10 minutes (range, 7-20 minutes). Comparison between outcomes for different hand disorders and different procedures for the same hand disorders is possible with this questionnaire. The MHQ was also found to be useful when independent scores from multiple domains were required. Another unique feature of this questionnaire is that four domains measure both right and left hand outcomes and, hence, comparison with an unaffected control hand is possible. The MHQ can also measure function and symptom outcomes separately. The authors admit that the generalisability of the findings of the study is not possible because of the high proportion of the female population in the study population of 50 patients.
Limitations
The questionnaire was tested in a small sample size of 200 patients with mixed hand disorders and has not been exclusively validated in patients with CTS. The scale did not measure social and mental health. Responsiveness of the MHQ was not established by the developer. The acceptability and generalisability of the MHQ is not evaluated. Floor effects and ceiling effects were not recorded. Crosscultural validation has not been carried out. There is only one report on the use of this questionnaire for patients with CTS from independent centres.
Historical-Objective scale (Hi-Ob scale)
Conceptual framework This is a physician-oriented scale based on clinical history and physical examination findings. Giannini et al. [9] developed this score in 2002 and validated it in 168 consecutive CTS hands. The scale was based on the parameters outlined in Table 2 . Based on the presence of findings A to D, the patients were grouped into one of the five stages. The parameter E was marked as a dichotomous variable of yes or no. Hence, the final score is the combination of stage and the dichotomous variable (e.g. 2P or 3 or 4P). Criteria to group the patients into different stages based on the four parameters have been established.
Validity
The authors established validity by showing a high correlation between the Hi-Ob score and symptom and functional subscales of BCTQ and neuro-physiological measures.
Reliability and responsiveness
Reproducibility was established by demonstrating a percentage agreement of 78% and a Cohen coefficient of 0.69, and good responsiveness was also noted.
Other features
It is claimed to be both a physician-and patient-oriented programme, and better than just patient-oriented programs.
Limitations
This scale has numerous disadvantages, such as that it has never been used or validated by independent researchers, cross-cultural validation has not been done and variables like time to fill in questionnaire and commonly missed items have not been established. The scale does not cover different components of physical health (symptoms, function, ADL, dexterity, satisfaction) or social and mental health.
Patient Evaluation Measure (PEM)
Conceptual framework
Reported by Macey et al. [19] in 1995, PEM is a self administered measure of physical health (Table 2) . It uses a visual analogue score and has three components: patients' opinion on the delivery of care, hand health profile and overall assessment. Nothing has been mentioned about item generation, item reduction or other aspects of the development process.
Validity
The authors, in their initial report, described the components of the questionnaire and failed to mention anything about the development process and the validation process. Interestingly, the first report on the validation of this measure was published in the year 2000, nearly five years after the initial report, from an independent centre by demonstrating a high correlation between the grip strength and level of distress items in the questionnaire. In 2005, Hobby et al. [12] assessed its usefulness in patients with CTS and validated it by demonstrating its high correlation with the DASH score and objective measures like grip strength, sensibility and dexterity.
Reliability
The overall reliability of PEM was found to be 0.83 and the inter-item consistency was 0.88. Hobby et al. [12] also revealed a high IC of PEM (0.94).
Responsiveness
Hobby et al. [12] also reported high responsiveness, with an SRM of 0.94.
Other features
Simplicity was assessed by quantifying the help needed to fill in the questionnaire and the developers claim that the questionnaire is very simple to fill. This questionnaire is electronically available and is free.
Limitations
This measure has not been used by anyone except its developers, the study population was a non-random sample, the sample size was too low (35 patients) with no mention of patient characteristics, no cross-cultural validation was carried out and it measures only the physical components of health.
Disability of Arm, Shoulder and Hand questionnaire (DASH)
Conceptual framework This is a region-specific scale which is a joint initiative of the American Academy of Orthopaedic Surgeons (AAOS), 
Validity
Hobby et al. [12] established criteria validity by demonstrating a strong correlation between DASH and PEM. Apart from this report, no other study has assessed the validity of this questionnaire in patients with CTS.
Reliability
The test-retest reliability of DASH was demonstrated by Greenslade et al. [10] (intra-class correlation, ICC=0.9).
Responsiveness
Greenslade et al. [10] recorded a responsiveness of SRM= 0.66 for DASH. Gummesson et al. [11] in 2003 studied the longitudinal construct validity of the DASH questionnaire and found that the SRM was 1.0 and the effect size was 0.7 for CTS. Gay et al. [7] compared the DASH responsiveness to the responsiveness of BCTQ and SF-36 and found DASH (SRM=1.13, ES=1.01) to have a better responsiveness than SF-36 (SRM=0.52, ES=0.57). Hobby et al. [12] in 2005 evaluated the responsiveness of DASH and found an effect size of 0.49. Similarly, Kotsis [16] demonstrated moderate responsiveness, with an SRM of 0.7.
Other features
Greenslade et al. [10] established the mean time to complete the questionnaire as 6.8 min and the minimal important change for the DASH score to be 10 points. It has been validated in the French, Spanish and Japanese languages [7, 8, 14, 22] .
Limitations
This questionnaire is extensively studied for other upper limb disorders but not for CTS. The IC of the questionnaire in patients with CTS, floor and ceiling effects and the commonly missed questions by carpal tunnel patients has not been established.
Discussion
It is evident from the critical analysis of some of the outcome measures used in patients with CTS that none of them can be considered to be the best or ideal outcome measure. There is scope for improvement for the outcome measures in CTS. Each measure has its own advantages and limitations. Hence, the clinician should select the outcome measure based on the primary purpose of their study. The clinician should consider other factors that will influence the choice, including the population selected, setting (hospital outpatient clinic, inpatient), mode of administration (postal or personal) and time constraints (shorter versus longer).
